AZD7986, oral solution, 1 to 50 mg/mL + Placebo, oral solution
Phase 1Completed 1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Safety, Pharmacokinetics, Pharmacodynamics, Food Effect
Conditions
Safety, Pharmacokinetics, Pharmacodynamics, Food Effect
Trial Timeline
Dec 3, 2014 → Aug 3, 2016
NCT ID
NCT02303574About AZD7986, oral solution, 1 to 50 mg/mL + Placebo, oral solution
AZD7986, oral solution, 1 to 50 mg/mL + Placebo, oral solution is a phase 1 stage product being developed by AstraZeneca for Safety, Pharmacokinetics, Pharmacodynamics, Food Effect. The current trial status is completed. This product is registered under clinical trial identifier NCT02303574. Target conditions include Safety, Pharmacokinetics, Pharmacodynamics, Food Effect.
What happened to similar drugs?
3 of 4 similar drugs in Safety, Pharmacokinetics, Pharmacodynamics, Food Effect were approved
Approved (3) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02303574 | Phase 1 | Completed |
Competing Products
20 competing products in Safety, Pharmacokinetics, Pharmacodynamics, Food Effect